Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

High Myostatin Serum Related with High Prevalence of Sarcopenia Among Elderly Population in Pedawa Village, Bali, Indonesia

The Indonesian Biomedical Journal · Vol. 11 No. 3 (2019) · hlm. 293–298

DOI
10.18585/inabj.v11i3.822
ISSN
2085-3297, 2355-9179
Terbit
2019-12-03
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Sarcopenia is defined as a decrease in muscle mass accompanied by a decrease in muscle strength and performance. Sarcopenia arises from the disruption of the complex balance between anabolic and catabolic factors. Myostatin strongly influences muscle growth inhibition. Deletion and function loss of myostatin causes hyperplasia and skeletal muscle hypertrophy.METHODS: This study was an analytical cross-sectional study. Seventy respondents aged ≥60 years in Pedawa Village, Bali, Indonesia were selected by using the stratified random sampling technique. Sarcopenia status was assessed according to Asian Working Group for Sarcopenia (AWGS) criteria, including muscle mass, grip strength, and walking speed. While the myostatin serum levels was measured by enzyme-linked immunosorbent assay (ELISA).RESULTS: The incidence of sarcopenia in the elderly was 45 people (64.3%). Based on the analysis, there was a significant difference between myostatin levels in sarcopenia subjects (47.59 ng/mL) and non-sarcopenia subjects (39.7 ng/mL). Based on the statistical calculations, it was determined that the cut-off range of myostatin levels was 48.91 ng/mL. The prevalence ratio of sarcopenia incidence based on the myostatin levels in the elderly was 3.84, while based on the combination of age risk and myostatin levels was 9.75.CONCLUSION: Based of the data, there are significant differences of myostatin level between elderly people with and without sarcopenia. The prevalence of high myostatin levels in elderly is almost 4 times higher than low myostatin levels in the elderly.KEYWORDS: myostatin, sarcopenia, elderly

Kata kunci

Jaringan kolaborasi para penulis

25 penulis · 87 tautan kepenulisan bersama · 17 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Udayana University
  • Rumah Sakit Umum Pusat Sanglah Denpasar
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Anak Agung Ngurah SubawaUdayana University2
I Wayan Gede Artawan Eka PutraUdayana University2
Ni Putu Sukma Sumantri PrabandariUdayana University2
Ni Kadek MulyantariUdayana University2
Made SukmawatiUdayana University2
Ni Nyoman MahartiniUdayana University2
Ida Ayu Pradnya ParamitaRumah Sakit Umum Pusat Sanglah Denpasar1
Yenny KandariniUdayana University1
Gede Wira MahaditaUdayana University1
Ketut SuegaUdayana University1
I Gde Raka WidianaUdayana University1
Sianny HerawatiRumah Sakit Umum Pusat Sanglah Denpasar1
Ni Made LinawatiUdayana University1
Luh Putu Ratna SundariUdayana University1
I Gusti Kamasan Nyoman ArijanaUdayana University1
I Wayan Rai WidartaUdayana University1
Juven LuviantoUdayana University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">High Myostatin Serum Related with High Prevalence of Sarcopenia Among Elderly Population in Pedawa Village, Bali, Indonesia</dc:title><dc:creator>I Gusti Putu Suka Aryana</dc:creator><dc:creator>I Nyoman Astika</dc:creator><dc:creator>Raden Ayu Tuty Kuswardhani</dc:creator><dc:creator>Ida Bagus Putu Putrawan</dc:creator><dc:creator>Ni Ketut Rai Purnami</dc:creator><dc:creator>Wayan Giri Putra Semaradana</dc:creator><dc:creator>Anak Agung Wiradewi Lestari</dc:creator><dc:creator>I Nyoman Wande</dc:creator><dc:subject>myostatin</dc:subject><dc:subject>sarcopenia</dc:subject><dc:subject>older adults</dc:subject><dc:subject>sarcopenia prevalence</dc:subject><dc:subject>muscle mass</dc:subject><dc:subject>grip strength</dc:subject><dc:subject>walking speed</dc:subject><dc:subject>Asian Working Group for Sarcopenia criteria</dc:subject><dc:subject>cut-off values</dc:subject><dc:description xml:lang="en">BACKGROUND: Sarcopenia is defined as a decrease in muscle mass accompanied by a decrease in muscle strength and performance. Sarcopenia arises from the disruption of the complex balance between anabolic and catabolic factors. Myostatin strongly influences muscle growth inhibition. Deletion and function loss of myostatin causes hyperplasia and skeletal muscle hypertrophy.METHODS: This study was an analytical cross-sectional study. Seventy respondents aged ≥60 years in Pedawa Village, Bali, Indonesia were selected by using the stratified random sampling technique. Sarcopenia status was assessed according to Asian Working Group for Sarcopenia (AWGS) criteria, including muscle mass, grip strength, and walking speed. While the myostatin serum levels was measured by enzyme-linked immunosorbent assay (ELISA).RESULTS: The incidence of sarcopenia in the elderly was 45 people (64.3%). Based on the analysis, there was a significant difference between myostatin levels in sarcopenia subjects (47.59 ng/mL) and non-sarcopenia subjects (39.7 ng/mL). Based on the statistical calculations, it was determined that the cut-off range of myostatin levels was 48.91 ng/mL. The prevalence ratio of sarcopenia incidence based on the myostatin levels in the elderly was 3.84, while based on the combination of age risk and myostatin levels was 9.75.CONCLUSION: Based of the data, there are significant differences of myostatin level between elderly people with and without sarcopenia. The prevalence of high myostatin levels in elderly is almost 4 times higher than low myostatin levels in the elderly.KEYWORDS: myostatin, sarcopenia, elderly</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2019-12-03</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v11i3.822</dc:identifier><dc:identifier>10.18585/inabj.v11i3.822</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 11 No 3 (2019); 293-298</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/822/448</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>